Important Message – Fraud Alert We have been made aware of fraudulent messages impersonating our company.
0
John Buckingham photo

DIVIDEND, INCOME, STOCKS

John Buckingham

Co-Founder, Executive Director - Investments,

Value87 Investment Partners

About John

John Buckingham co-founded Value87 Investment Partners in 2026, bringing nearly four decades of investment management experience to the firm. John Buckingham is editor-in-chief of A Patient Prospector, following 39 years with The Prudent Speculator. APP is a value-oriented publication that offers stock picks and market commentary, facts and figures designed to keep readers on the path to achieving their long-term investment objectives.

Throughout his career, Mr. Buckingham has been recognized for his independent investment research, market insights and Value perspective. He has been featured in Barron’s, The Wall Street Journal, MarketWatch, Forbes and others, while also making appearances on CNBC, Bloomberg and Fox Business. He is a recognized industry commentator and regularly speaks at prominent investment conferences and events. 

John's Articles

View All Articles
HEALTHCARE image
ABT: An Attractive Bargain in the Healthcare Sector
Shares of Abbott Laboratories (ABT) are now down more than 22% in 2026. The medical device maker and healthcare products and services provider got no help from its Q1 earnings release. But we continue to think very highly of Abbott and its strong financial position, writes John Buckingham, editor of The Prudent Speculator.
John Buckingham photo
John Buckingham

HEALTHCARE

Tickers: ABT
HEALTHCARE image
ZBH: A Healthcare Equipment Stock for Patient Investors
“The stock market may not bring you undreamed-of rewards, but if you are willing to get rich slowly, it is the place to make or maintain a fortune,” said Al Frank 31 years ago. Zimmer Biomet Holdings Inc. (ZBH) is a stock to consider, suggests John Buckingham, editor of The Prudent Speculator.
John Buckingham photo
John Buckingham

HEALTHCARE

Tickers: ZBH
INDUSTRIALS image
APD: An Industrial Gas Giant Offering Compelling Value
Air Products & Chemicals Inc. (APD) fell more than 6% last week after announcing advanced talks with Yara International, a Norway-based fertilizer producer and global ammonia distributor, on two major projects in the US and Saudi Arabia. But our target price now stands at $360, observes John Buckingham, editor of The Prudent Speculator.
John Buckingham photo
John Buckingham

INDUSTRIALS

Tickers: APD
CONSUMER DISCRETIONARY image
IP: A Turnaround Play Too Attractive to Pass Up
This is a market of stocks, not simply a stock market. So, while pundits fret about a broad-based index like the S&P 500 (^SPX) trading at a nosebleed forward P/E of 25.7, those willing to venture into individual equities have plenty of inexpensive names from which to choose. I like International Paper Co. (IP), writes John Buckingham, editor of The Prudent Speculator.
John Buckingham photo
John Buckingham

CONSUMER DISCRETIONARY

Tickers: SPX, IP

John's Videos

View All Videos
Sleeping Better at Night – The Value of Dividends
Sleeping Better at Night – The Value of Dividends

Learn from the editor of the top-ranked newsletter, The Prudent Speculator, about why inexpensively priced dividend-paying stocks can help investors always remember the famous quotation, “If you do not change direction, you may end up where you are heading.” Plus, receive his current undervalued yield-focused stock picks. 

John Buckingham Photo
John Buckingham

STOCKS

 
31:13
Even Economists Can't Predict the Economy…So Investors Shouldn't Even Try! Do THIS instead...
Even Economists Can't Predict the Economy…So Investors Shouldn't Even Try! Do THIS instead...
John Buckingham, Editor of the Prudent Speculator newsletter, points out a simple truth: Even economists can't predict the economy! So in this interview, he explains why investors shouldn't even try -
John Buckingham Photo
John Buckingham

STOCKS

 
5:15
Protect Your Portfolio From the Start
Protect Your Portfolio From the Start
While media market gurus are recommending traders protect their portfolio now that the market is experiencing higher volatility.
John Buckingham Photo
John Buckingham

STRATEGIES

 
5:36
Why Recent Equity Volatility is Normal
Why Recent Equity Volatility is Normal
John Buckingham explains why the recent equity market volatility is normal and healthy for the markets.
John Buckingham Photo
John Buckingham

STOCKS

 
5:41

Newsletter Contributions

A Patient Prospector

John Buckingham is Editor-in-Chief of A Patient Prospector, following 39 years with The Prudent Speculator. APP is a value-oriented publication that offers stock picks and market commentary, facts and figures designed to keep readers on the path to achieving their long-term investment objectives.

Learn More